<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />




<title>Anticoagulantia</title>

<script src="site_libs/header-attrs-2.29/header-attrs.js"></script>
<script src="site_libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="site_libs/bootstrap-3.3.5/css/flatly.min.css" rel="stylesheet" />
<script src="site_libs/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="site_libs/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="site_libs/jqueryui-1.13.2/jquery-ui.min.js"></script>
<link href="site_libs/tocify-1.9.1/jquery.tocify.css" rel="stylesheet" />
<script src="site_libs/tocify-1.9.1/jquery.tocify.js"></script>
<script src="site_libs/navigation-1.1/tabsets.js"></script>
<link href="site_libs/highlightjs-9.12.0/default.css" rel="stylesheet" />
<script src="site_libs/highlightjs-9.12.0/highlight.js"></script>
<link href="site_libs/htmltools-fill-0.5.8.1/fill.css" rel="stylesheet" />
<script src="site_libs/htmlwidgets-1.6.4/htmlwidgets.js"></script>
<link href="site_libs/datatables-css-0.0.0/datatables-crosstalk.css" rel="stylesheet" />
<script src="site_libs/datatables-binding-0.33/datatables.js"></script>
<link href="site_libs/dt-core-1.13.6/css/jquery.dataTables.min.css" rel="stylesheet" />
<link href="site_libs/dt-core-1.13.6/css/jquery.dataTables.extra.css" rel="stylesheet" />
<script src="site_libs/dt-core-1.13.6/js/jquery.dataTables.min.js"></script>
<link href="site_libs/crosstalk-1.2.1/css/crosstalk.min.css" rel="stylesheet" />
<script src="site_libs/crosstalk-1.2.1/js/crosstalk.min.js"></script>
<link href="site_libs/font-awesome-6.5.2/css/all.min.css" rel="stylesheet" />
<link href="site_libs/font-awesome-6.5.2/css/v4-shims.min.css" rel="stylesheet" />

<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>

<style type="text/css">code{white-space: pre;}</style>
<script type="text/javascript">
if (window.hljs) {
  hljs.configure({languages: []});
  hljs.initHighlightingOnLoad();
  if (document.readyState && document.readyState === "complete") {
    window.setTimeout(function() { hljs.initHighlighting(); }, 0);
  }
}
</script>





<style type="text/css">
/* for pandoc --citeproc since 2.11 */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>




<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
details > summary > p:only-child {
  display: inline;
}
pre code {
  padding: 0;
}
</style>


<style type="text/css">
.dropdown-submenu {
  position: relative;
}
.dropdown-submenu>.dropdown-menu {
  top: 0;
  left: 100%;
  margin-top: -6px;
  margin-left: -1px;
  border-radius: 0 6px 6px 6px;
}
.dropdown-submenu:hover>.dropdown-menu {
  display: block;
}
.dropdown-submenu>a:after {
  display: block;
  content: " ";
  float: right;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
  border-width: 5px 0 5px 5px;
  border-left-color: #cccccc;
  margin-top: 5px;
  margin-right: -10px;
}
.dropdown-submenu:hover>a:after {
  border-left-color: #adb5bd;
}
.dropdown-submenu.pull-left {
  float: none;
}
.dropdown-submenu.pull-left>.dropdown-menu {
  left: -100%;
  margin-left: 10px;
  border-radius: 6px 0 6px 6px;
}
</style>

<script type="text/javascript">
// manage active state of menu based on current page
$(document).ready(function () {
  // active menu anchor
  href = window.location.pathname
  href = href.substr(href.lastIndexOf('/') + 1)
  if (href === "")
    href = "index.html";
  var menuAnchor = $('a[href="' + href + '"]');

  // mark the anchor link active (and if it's in a dropdown, also mark that active)
  var dropdown = menuAnchor.closest('li.dropdown');
  if (window.bootstrap) { // Bootstrap 4+
    menuAnchor.addClass('active');
    dropdown.find('> .dropdown-toggle').addClass('active');
  } else { // Bootstrap 3
    menuAnchor.parent().addClass('active');
    dropdown.addClass('active');
  }

  // Navbar adjustments
  var navHeight = $(".navbar").first().height() + 15;
  var style = document.createElement('style');
  var pt = "padding-top: " + navHeight + "px; ";
  var mt = "margin-top: -" + navHeight + "px; ";
  var css = "";
  // offset scroll position for anchor links (for fixed navbar)
  for (var i = 1; i <= 6; i++) {
    css += ".section h" + i + "{ " + pt + mt + "}\n";
  }
  style.innerHTML = "body {" + pt + "padding-bottom: 40px; }\n" + css;
  document.head.appendChild(style);
});
</script>

<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before, .tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "\e259";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "\e258";
  font-family: 'Glyphicons Halflings';
  border: none;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->



<style type="text/css">

#TOC {
  margin: 25px 0px 20px 0px;
}
@media (max-width: 768px) {
#TOC {
  position: relative;
  width: 100%;
}
}

@media print {
.toc-content {
  /* see https://github.com/w3c/csswg-drafts/issues/4434 */
  float: right;
}
}

.toc-content {
  padding-left: 30px;
  padding-right: 40px;
}

div.main-container {
  max-width: 1200px;
}

div.tocify {
  width: 20%;
  max-width: 260px;
  max-height: 85%;
}

@media (min-width: 768px) and (max-width: 991px) {
  div.tocify {
    width: 25%;
  }
}

@media (max-width: 767px) {
  div.tocify {
    width: 100%;
    max-width: none;
  }
}

.tocify ul, .tocify li {
  line-height: 20px;
}

.tocify-subheader .tocify-item {
  font-size: 0.90em;
}

.tocify .list-group-item {
  border-radius: 0px;
}


</style>



</head>

<body>


<div class="container-fluid main-container">


<!-- setup 3col/9col grid for toc_float and main content  -->
<div class="row">
<div class="col-xs-12 col-sm-4 col-md-3">
<div id="TOC" class="tocify">
</div>
</div>

<div class="toc-content col-xs-12 col-sm-8 col-md-9">




<div class="navbar navbar-default  navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-bs-toggle="collapse" data-target="#navbar" data-bs-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="index.html">Veel gestelde vragen over hemostase</a>
    </div>
    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li>
  <a href="bloedingsanamnese.html">
    <span class="fa fa-solid fa-droplet"></span>
     
    Bloedingsanamnese
  </a>
</li>
<li>
  <a href="primairehemostase.html">
    <span class="fa fa-sharp fa-regular fa-circle"></span>
     
    Primaire hemostase
  </a>
</li>
<li>
  <a href="secundairehemostase.html">
    <span class="fa fa-solid fa-vial"></span>
     
    Secundaire hemostase
  </a>
</li>
<li>
  <a href="antico.html">
    <span class="fa fa-solid fa-syringe"></span>
     
    Anticoagulantia
  </a>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        
      </ul>
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

<div id="header">



<h1 class="title toc-ignore">Anticoagulantia</h1>

</div>


<div
id="ik-heb-een-patient-met-een-trombose-welke-stolfactoren-moet-ik-bepalen-voor-trombofiliescreening"
class="section level2">
<h2>Ik heb een patient met een trombose, welke stolfactoren moet ik
bepalen voor trombofiliescreening?</h2>
<ol style="list-style-type: decimal">
<li><p>Wacht eerst tot na de acute fase, bij infectie/inflammatie kunnen
stolfactoren vals verhoogd of verlaagd zijn door verbruik of door de
acute fase.</p></li>
<li><p>Indien de trombose CVC gerelateerd is kan er bij een eerste
trombose afgewacht worden voor trombofiliescreening te starten.<span
class="citation"><sup>1</sup></span></p></li>
<li><p>Voor verdere testing naar trombofilie, test:</p></li>
</ol>
<ul>
<li>Proteine C (deficientie)</li>
<li>Proteine S (deficientie)</li>
<li>Antitrombine (deficientie)</li>
<li>F. VIII (overactiviteit)</li>
<li>APC (activated proteine C) resistentie</li>
<li>F. V Leiden mutatie indien APC resistentie aanwezig</li>
<li>Protrombine G20210A mutatie. Deze mutatie zorgt voor een verhoogde
protrombine concentratie en verhoogt het risico op een VTE 3 tot 4x
indien men heterozygoot is voor de mutatie<span
class="citation"><sup>2</sup></span>. Er is geen behandeling nodig als
dit asymptomatisch is, maar bij situaties met een verhoogd risico op
trombose (chirurgie, centrale katheters) is het belangrijk
profylactische antico op te starten.</li>
<li>Antifosfolipide-antilichamen: lupus anticoagulans, anticardiolipine,
beta-2-glycoproteine</li>
</ul>
<p>Over de rol van homocysteine is er discussie en routine testing is
niet aangewezen.<span class="citation"><sup>3</sup></span></p>
<hr />
</div>
<div id="wat-zijn-de-indicaties-voor-doacs-bij-kinderen"
class="section level2">
<h2>Wat zijn de indicaties voor DOACs bij kinderen?</h2>
<div id="dabigatranpradaxa" class="section level3">
<h3>Dabigatran/Pradaxa</h3>
<p>Indicatie: behandeling en preventie van recidief van veneuze
trombo-embolie (VTE). Bron: BCFI.</p>
<p>Terugbetaling indien:</p>
<ul>
<li>Lichaamsgewicht ≥30 kg</li>
<li>Doorgemaakte DVT of longembool</li>
<li>Minstens 5 dagen parenterale antistolling ontvangen</li>
<li>Maximaal 12 maanden</li>
</ul>
<p>Attest: RIZIV <a
href="https://webappsa.riziv-inami.fgov.be/ssp/RequestForms/Home/GetFile?requestFormId=221939"
class="uri">https://webappsa.riziv-inami.fgov.be/ssp/RequestForms/Home/GetFile?requestFormId=221939</a></p>
</div>
<div id="rivaroxabanxarelto" class="section level3">
<h3>Rivaroxaban/Xarelto</h3>
<p>Indicatie: behandeling en preventie van recidief van veneuze
trombo-embolie (VTE). Bron: BCFI.</p>
<p>Terugbetaling indien:</p>
<ul>
<li>Vanaf 8 jaar</li>
<li>Doorgemaakte DVT of longembool</li>
<li>Minstens 5 dagen parenterale antistolling ontvangen</li>
<li>Maximaal 12 maanden</li>
</ul>
<p>Attest: RIZIV <a
href="https://webappsa.riziv-inami.fgov.be/ssp/RequestForms/Home/GetFile?requestFormId=216390"
class="uri">https://webappsa.riziv-inami.fgov.be/ssp/RequestForms/Home/GetFile?requestFormId=216390</a></p>
<hr />
</div>
</div>
<div id="hoelang-en-welke-antico-moet-ik-geven-bij-een-veneuze-trombose"
class="section level2">
<h2>Hoelang en welke antico moet ik geven bij een veneuze trombose?</h2>
<div class="float">
<img src="images/VTE.drawio.svg"
alt="Duur van anticoagulantia bij veneuze trombose bij kinderen.4" />
<div class="figcaption">Duur van anticoagulantia bij veneuze trombose
bij kinderen.<span class="citation"><sup>4</sup></span></div>
</div>
<hr />
</div>
<div
id="ik-heb-een-patient-onder-xareltorivaroxaban-waarbij-ik-een-procedure-plan-wat-moet-ik-doen"
class="section level2">
<h2>Ik heb een patient onder Xarelto/rivaroxaban waarbij ik een
procedure plan, wat moet ik doen?</h2>
<p>Xarelto en andere directe orale anticoagulantia werken door te binden
aan de actieve site van factor Xa, waardoor Xa geïnhibeerd wordt.</p>
<p>Xarelto heeft een halfwaardetijd van gemiddeld 4.2 uur bij
adolescenten, 3 uur bij kinderen tussen 2 tot 12 jaar, 1.9 uur bij
kinderen 0.5 tot &lt;2 jaar, en 1.6 uur bij kinderen &lt;0.5 jaar (met
renale klaring dus bij nierinsufficientie neemt de halfwaardetijd
toe).<span class="citation"><sup>5</sup></span>;<span
class="citation"><sup>6</sup></span></p>
<p>Bij patienten met een normale nierfunctie dient Xarelto gestopt te
worden 24u op voorhand bij een procedure met laag bloedingsrisico en 48u
bij een procedure met een hoog bloedingsrisico.<span
class="citation"><sup>7</sup></span> en <a
href="https://cpthn.ca/wp-content/uploads/2023/01/CPTHN-Rivaroxaban-Guidance-Document_Final-Sep-2021-002.pdf">2</a></p>
<div class="datatables html-widget html-fill-item" id="htmlwidget-82c77ac5fb4824309e44" style="width:100%;height:auto;"></div>
<script type="application/json" data-for="htmlwidget-82c77ac5fb4824309e44">{"x":{"filter":"none","vertical":false,"data":[["Tandextracties","Dermatologische procedures (bv biopsie)","Endoscopie of colonoscopie (+/- biopsie)","Beenmergpunctie","Lumbaalpunctie","Andere abdominale surgery (e.g., laparoscopische cholecystectomie, herniaherstel)",null],["Neurochirurgie","Neuraxiale anesthesie (spinaal or epiduraal)","Hartchirurgie","Majeure abdominale chirurgie","Thoraxchirurgie","Extensieve tumorectomie","Lever of nierbiopsie"]],"container":"<table class=\"display\">\n  <thead>\n    <tr>\n      <th>MILD/MATIG RISICO<\/th>\n      <th>HOOG RISICO<\/th>\n    <\/tr>\n  <\/thead>\n<\/table>","options":{"dom":"t","ordering":false,"info":false,"paging":false,"columnDefs":[{"name":"MILD/MATIG RISICO","targets":0},{"name":"HOOG RISICO","targets":1}],"order":[],"autoWidth":false,"orderClasses":false}},"evals":[],"jsHooks":[]}</script>
</div>
<div id="referenties" class="section level2">
<h2>Referenties</h2>
<div class="#refs">

</div>
<div id="refs" class="references csl-bib-body">
<div id="ref-neshat-vahid_etal16" class="csl-entry">
<div class="csl-left-margin">1. </div><div
class="csl-right-inline">Neshat-Vahid S, Pierce R, Hersey D, Raffini LJ,
Faustino EVS. <a href="https://doi.org/10.1111/jth.13388">Association of
thrombophilia and catheter-associated thrombosis in children: A
systematic review and meta-analysis</a>. Journal of Thrombosis and
Haemostasis. 2016 Sep;14(9):1749–58. </div>
</div>
<div id="ref-Increased" class="csl-entry">
<div class="csl-left-margin">2. </div><div
class="csl-right-inline">Increased <span>Risk</span> for <span>Venous
Thrombosis</span> in <span>Carriers</span> of the <span>Prothrombin
G</span><span><span
class="math inline">\(\rightarrow\)</span></span><span>A20210 Gene
Variant</span> <span></span> <span>Annals</span> of <span>Internal
Medicine</span>.
https://www.acpjournals.org/doi/10.7326/0003-4819-129-2-199807150-00003?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub%20%200pubmed;
</div>
</div>
<div id="ref-Homocysteine" class="csl-entry">
<div class="csl-left-margin">3. </div><div
class="csl-right-inline">Homocysteine and venous
thromboembolism—<span>Is</span> there any link? -
<span>ScienceDirect</span>.
https://www.sciencedirect.com/science/article/pii/S001086501300009X;
</div>
</div>
<div id="ref-Venous" class="csl-entry">
<div class="csl-left-margin">4. </div><div
class="csl-right-inline">Venous thrombosis and thromboembolism
(<span>VTE</span>) in children: <span>Treatment</span>, prevention, and
outcome - <span>UpToDate</span>.
https://www.uptodate.com/contents/venous-thrombosis-and-thromboembolism-vte-in-children-treatment-prevention-and-outcome;
</div>
</div>
<div id="ref-polaniagutierrez_rocuts24" class="csl-entry">
<div class="csl-left-margin">5. </div><div
class="csl-right-inline">Polania Gutierrez JJ, Rocuts KR. <a
href="https://www.ncbi.nlm.nih.gov/pubmed/32491522">Perioperative
<span>Anticoagulation Management</span></a>. In:
<span>StatPearls</span>. Treasure Island (FL): StatPearls Publishing;
2024. </div>
</div>
<div id="ref-XARELTO" class="csl-entry">
<div class="csl-left-margin">6. </div><div
class="csl-right-inline"><span>XARELTO</span><span></span> (rivaroxaban)
<span></span> <span>Healthcare Professional Website</span>.
https://www.xareltohcp.com/pediatric-vte/; </div>
</div>
<div id="ref-Use" class="csl-entry">
<div class="csl-left-margin">7. </div><div class="csl-right-inline">Use
of <span>XARELTO</span> in <span>Perioperative Use</span>.
https://www.janssenscience.com/products/xarelto/medical-content/use-of-xarelto-in-perioperative-use#references-content;
</div>
</div>
</div>
</div>



</div>
</div>

</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->

<script>
$(document).ready(function ()  {

    // temporarily add toc-ignore selector to headers for the consistency with Pandoc
    $('.unlisted.unnumbered').addClass('toc-ignore')

    // move toc-ignore selectors from section div to header
    $('div.section.toc-ignore')
        .removeClass('toc-ignore')
        .children('h1,h2,h3,h4,h5').addClass('toc-ignore');

    // establish options
    var options = {
      selectors: "h1,h2,h3",
      theme: "bootstrap3",
      context: '.toc-content',
      hashGenerator: function (text) {
        return text.replace(/[.\\/?&!#<>]/g, '').replace(/\s/g, '_');
      },
      ignoreSelector: ".toc-ignore",
      scrollTo: 0
    };
    options.showAndHide = true;
    options.smoothScroll = true;

    // tocify
    var toc = $("#TOC").tocify(options).data("toc-tocify");
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
